JP2017528496A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528496A5 JP2017528496A5 JP2017515948A JP2017515948A JP2017528496A5 JP 2017528496 A5 JP2017528496 A5 JP 2017528496A5 JP 2017515948 A JP2017515948 A JP 2017515948A JP 2017515948 A JP2017515948 A JP 2017515948A JP 2017528496 A5 JP2017528496 A5 JP 2017528496A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- fluorine
- group
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *c1c(C(N*=C)=O)c(*)cc(*#C)c1 Chemical compound *c1c(C(N*=C)=O)c(*)cc(*#C)c1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14186082.5 | 2014-09-24 | ||
| EP14186082 | 2014-09-24 | ||
| PCT/EP2015/071656 WO2016046164A1 (de) | 2014-09-24 | 2015-09-22 | Substituierte oxopyridin-derivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017528496A JP2017528496A (ja) | 2017-09-28 |
| JP2017528496A5 true JP2017528496A5 (enExample) | 2018-10-11 |
| JP6517925B2 JP6517925B2 (ja) | 2019-05-22 |
Family
ID=51589181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017515948A Expired - Fee Related JP6517925B2 (ja) | 2014-09-24 | 2015-09-22 | 置換されたオキソピリジン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170298052A1 (enExample) |
| EP (1) | EP3197873B1 (enExample) |
| JP (1) | JP6517925B2 (enExample) |
| CN (1) | CN106687458B (enExample) |
| CA (1) | CA2961981A1 (enExample) |
| ES (1) | ES2713624T3 (enExample) |
| WO (1) | WO2016046164A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2722423T3 (es) * | 2014-09-24 | 2019-08-12 | Bayer Pharma AG | Derivados de oxopiridina sustituidos |
| US20190119213A1 (en) * | 2015-03-19 | 2019-04-25 | Bayer Pharma Aktiengesellschaft | Oxo-pyridine-derivatives as factor xia inhibitors for the treatment of thrombosis |
| JO3703B1 (ar) | 2015-07-09 | 2021-01-31 | Bayer Pharma AG | مشتقات أوكسوبيريدين مستبدلة |
| BR112020016856A2 (pt) | 2018-02-27 | 2020-12-22 | Jiangsu Hengrui Medicine Co., Ltd. | Forma de cristal do derivado de oxopicolinamida e método de preparação da mesma |
| BR112020018237A2 (pt) | 2018-04-10 | 2020-12-29 | Bayer Pharma Aktiengesellschaft | Derivado de oxipiridina substituída |
| CA3124296A1 (en) | 2018-12-21 | 2020-06-25 | Bayer Aktiengesellschaft | Substituted oxopyridine derivatives |
| SG11202104384PA (en) | 2018-12-21 | 2021-05-28 | Bayer Ag | Substituted oxopyridine derivatives |
| CN112022848B (zh) * | 2020-08-13 | 2022-02-22 | 中南大学湘雅二医院 | 索拉非尼在治疗1型糖尿病中的应用 |
| CN115947680B (zh) * | 2021-10-09 | 2025-09-23 | 山东新时代药业有限公司 | 一种替罗非班中间体化合物及其制备方法 |
| CN116262740A (zh) * | 2022-11-18 | 2023-06-16 | 成都施贝康生物医药科技有限公司 | 新型氧代吡啶类化合物及其制备方法和用途 |
| CN116535392B (zh) * | 2023-06-26 | 2023-09-05 | 成都施贝康生物医药科技有限公司 | 一种氧代吡啶类化合物的制备方法及中间体和应用 |
| CN116751136B (zh) * | 2023-06-21 | 2025-08-29 | 成都施贝康生物医药科技有限公司 | 氧代吡啶类化合物的新型制备方法及关键中间体 |
| CN116874387B (zh) * | 2023-06-21 | 2025-08-26 | 成都施贝康生物医药科技有限公司 | 氧代吡啶类化合物的新型制备方法及关键中间体 |
| CN116730861A (zh) * | 2023-06-21 | 2023-09-12 | 成都施贝康生物医药科技有限公司 | 氧代吡啶类化合物的新型制备方法及关键中间体 |
| CN117164566B (zh) * | 2023-09-07 | 2025-06-06 | 成都施贝康生物医药科技有限公司 | 一种氧代哒嗪类化合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| CA2651303A1 (en) * | 2006-05-05 | 2007-11-15 | Millennium Pharmaceuticals, Inc. | Factor xa inhibitors |
| JP5419706B2 (ja) * | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
| ES2765891T3 (es) * | 2011-12-21 | 2020-06-11 | Ono Pharmaceutical Co | Derivados de piridinona y pirimidinona como inhibidores del factor XIa |
| GB2497806A (en) * | 2011-12-21 | 2013-06-26 | Ono Pharmaceutical Co | Pyridinone and pyrimidinone derivatives as factor XIa inhibitors |
-
2015
- 2015-09-22 EP EP15766512.6A patent/EP3197873B1/de not_active Not-in-force
- 2015-09-22 US US15/513,988 patent/US20170298052A1/en not_active Abandoned
- 2015-09-22 JP JP2017515948A patent/JP6517925B2/ja not_active Expired - Fee Related
- 2015-09-22 WO PCT/EP2015/071656 patent/WO2016046164A1/de not_active Ceased
- 2015-09-22 CA CA2961981A patent/CA2961981A1/en not_active Abandoned
- 2015-09-22 ES ES15766512T patent/ES2713624T3/es active Active
- 2015-09-22 CN CN201580051690.6A patent/CN106687458B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528496A5 (enExample) | ||
| JP2016535031A5 (enExample) | ||
| JP2016515562A5 (enExample) | ||
| JP2016525136A5 (enExample) | ||
| JP2016535732A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| PH12015502249A1 (en) | Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders | |
| JP2013542261A5 (enExample) | ||
| CN105636951A (zh) | 酰胺类衍生物及其可药用盐、其制备方法及其在医药上的应用 | |
| RU2009136445A (ru) | Способ получения высокочистого празугрель гидрохлорида | |
| JP2014114295A5 (enExample) | ||
| JP2014114305A5 (enExample) | ||
| JP2014509316A5 (enExample) | ||
| JP2012041365A5 (enExample) | ||
| JP2018516883A5 (enExample) | ||
| JP2016539092A5 (enExample) | ||
| JP2012532112A5 (enExample) | ||
| JP2018509426A5 (enExample) | ||
| JP2014521625A5 (enExample) | ||
| JP2009510044A5 (enExample) | ||
| JP2014508811A5 (enExample) | ||
| CA2864222A1 (en) | Cycloalkane derivative | |
| JP2015514061A5 (enExample) | ||
| JP2016503785A5 (enExample) | ||
| RU2015155585A (ru) | 4-алкинилимидазольное производное и лекарственное средство, включающее такое производное в качестве активного ингредиента |